Paul Tudor Jones’s ResMed RMD Stock Holding History

Paul Tudor Jones’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,700	Closed	-$325K	–	3040
2024 Q2	$325K	Buy	+1,700	New	+$345K	﹤0.01%	1983
2024 Q1	–	Sell	-9,800	Closed	-$1.69M	–	2700
2023 Q4	$1.69M	Buy	9,800 +1,000	+11%	+$154K	0.01%	1186
2023 Q3	$1.3M	Buy	+8,800	New	+$1.59M	0.01%	1163

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Paul Tudor Jones's RMD Position: Q2 2026 in Review

Paul Tudor Jones sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,796 shares — an estimated $372K sold.

Paul Tudor Jones first reported a position in RMD in Q2 2013 and held it in 29 quarters. The position peaked at $33.9M in Q1 2024. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Paul Tudor Jones reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
Paul Tudor Jones sold 1,796 ResMed shares in Q2 2026, an estimated $372K.
Paul Tudor Jones first reported a position in ResMed in Q2 2013 and held it in 29 quarters.
Paul Tudor Jones's ResMed position peaked at $33.9M in Q1 2024.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.